Stereotactic Body Radiotherapy Clinical Trials

30 clinical trials for Stereotactic Body Radiotherapy across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE) — RECRUITING · PHASE3
• Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases — RECRUITING · PHASE2
• Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities — RECRUITING · NA
• Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular Carcinoma — RECRUITING · NA
• Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC. — NOT_YET_RECRUITING · PHASE3
• Safety and Tolerability of Low Dose Radiotherapy Concurrent SBRT and PD-1 Inhibitors in Advanced NSCLC. — ACTIVE_NOT_RECRUITING · PHASE1
• Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy — NOT_YET_RECRUITING · PHASE3
• Early Magnetic Resonance Imaging Response of the Dominant Intraprostatic Lesion After Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer and Correlation With Prostate Specific Antigen Response — ACTIVE_NOT_RECRUITING
• Stereotactic Body RadioTherapy With Continuous Tracking for Primary and Secondary Renal Cancer — NOT_YET_RECRUITING · NA
• Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System — WITHDRAWN
• Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT — COMPLETED
• Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer — COMPLETED
• Safety and Efficacy of Stereotactic Body Radiotherapy in the Treatment of Hypertrophic Obstructive Cardiomyopathy — OTHER · NA
• Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease — ACTIVE_NOT_RECRUITING · NA
• LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT — OTHER
• Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors — OTHER · PHASE1
• Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer — NOT_YET_RECRUITING · NA
• Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer — OTHER
• Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis. — NOT_YET_RECRUITING · PHASE1
• Preoperative Stereotactic Body Radiotherapy (SBRT) Followed by Hepatectomy for Centrally Located Hepatocellular Carcinoma: a Prospective, Single-center, Phase I Study — OTHER · NA
• A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer — OTHER · NA
• Sintilimab Combined With Chemotherapy and SBRT in Limited Metastatic Head and Neck Squamous Cell Carcinoma (LM-HNSCC) — OTHER · PHASE2
• Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombosis — COMPLETED · NA
• Post SBRT Pulmonary Metastasectomy (PSPM) Trial — OTHER · NA
• Stereotactic Body Radiotherapy Boost After Palliative Radiotherapy for Spinal Cord Compression — OTHER · NA
• Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast Cancer — OTHER · PHASE2
• Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma — OTHER · NA
• Stereotactic Body Radiotherapy and Microwave Ablation for Recurrent Small Hepatocellular Carcinoma — OTHER · NA
• Improving REsectability in Pancreatic NEoplasms (IRENE) — OTHER · NA
• Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT — COMPLETED

Refine this search